PubRank

Philippe Chevalier

Author PubWeight™ 34.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007 2.29
2 Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm 2008 1.86
3 Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging 2009 1.42
4 Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010 1.40
5 Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 2010 1.21
6 Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet 2011 1.09
7 Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol 2005 1.08
8 5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy 2011 1.03
9 Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet 2010 1.00
10 New paradigms in telemedicine: ambient intelligence, wearable, pervasive and personalized. Stud Health Technol Inform 2004 0.97
11 Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol 2009 0.90
12 Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol 2012 0.89
13 Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J 2009 0.85
14 Design and evaluation of a transesophageal HIFU probe for ultrasound-guided cardiac ablation: simulation of a HIFU mini-maze procedure and preliminary ex vivo trials. IEEE Trans Ultrason Ferroelectr Freq Control 2013 0.84
15 Inflammation, a link between obesity and atrial fibrillation. Inflamm Res 2015 0.83
16 Right ventricular pump function after cardiac resynchronization therapy: a strain imaging study. Arch Cardiovasc Dis 2008 0.82
17 Long-standing bacteremia and endocarditis caused by Staphylococcus lugdunensis in a patient with an implantable cardioverter defibrillator. Clin Microbiol Infect 1997 0.82
18 Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol 2008 0.81
19 QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep 2008 0.81
20 Radiofrequency ablation of atrial fibrillation: the first 100 cases in Lyon. Int J Cardiol 2008 0.80
21 Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One 2013 0.80
22 Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace 2013 0.80
23 A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope. Heart Rhythm 2008 0.80
24 Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace 2012 0.80
25 The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs. J Anesth 2006 0.79
26 Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome. FEBS Lett 2009 0.79
27 Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status. Resuscitation 2012 0.79
28 Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol 2003 0.79
29 In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction. Ann Noninvasive Electrocardiol 2013 0.78
30 Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study. Circ Cardiovasc Imaging 2011 0.78
31 Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol 2012 0.78
32 Thymic size and muscle mass of HIV-infected asymptomatic children from Burkina Faso. J Acquir Immune Defic Syndr 2002 0.78
33 Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion. Resuscitation 2011 0.78
34 Myocarditis and cardiac channelopathies: a deadly association? Int J Cardiol 2011 0.76
35 Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the Prospective, Multicenter Mona Lisa Study). Am J Cardiol 2010 0.76
36 Scintigraphic spectrum of a patient population with suspected arrhythmogenic right ventricular dysplasia. Int J Cardiovasc Imaging 2011 0.76
37 Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study. Am Heart J 2010 0.76
38 High-tech catheter ablation: worth the cost? Arch Cardiovasc Dis 2009 0.75
39 Response to letter by Robert M. Hamilton based on "Prophylactic radiofrequency ablation in asymptomatic patients with Wolff-Parkinson-White is not yet a good strategy: a decision analysis" by Chevalier et al. Circ Arrhythm Electrophysiol 2013 0.75
40 Scaring myocardial scars: new targets for the electrical fairy? J Am Coll Cardiol 2012 0.75
41 Ropivacaine combined with various anti-arrhythmic drugs results in mild alterations in myocardial contractility in pigs. Can J Anaesth 2003 0.75
42 Effects of amlodipine and perindoprilate on the structure and function of mitochondria in ventricular cardiomyocytes during ischemia-reperfusion in the pig. Fundam Clin Pharmacol 2014 0.75
43 Short-coupled variant of torsades de pointes with intractable ventricular fibrillation: lifesaving effect of cardiopulmonary bypass. J Cardiovasc Electrophysiol 2003 0.75
44 A heartless brain. Europace 2013 0.75
45 Persistent abnormal intraventricular conduction after myocarditis revealed by recurrent syncopes. J Electrocardiol 2013 0.75
46 Beat-to-beat variations of the electrocardiogram in survivors of sudden death without structural heart disease. J Electrocardiol 2006 0.75
47 Monitoring of heart rate variability in heart failure patients with cardiac resynchronisation therapy: interest of continuous and didactic algorithm. Int J Cardiol 2009 0.75
48 Spatiotemporal electrocardiographic characterization of ventricular depolarization and repolarization abnormalities in long QT syndrome. J Electrocardiol 2007 0.75
49 Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion. Fundam Clin Pharmacol 2013 0.75
50 Pulmonary vein hematoma after atrial fibrillation cryoablation: a new complication. Heart Rhythm 2012 0.75
51 Accelerated coronary atherosclerosis revealed by arrhythmogenic coronary spasm. Cardiology 2011 0.75
52 Wavelet transform for analysis of heart rate variability preceding ventricular arrhythmias in patients with ischemic heart disease. Int J Cardiol 2005 0.75
53 Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals. Cochrane Database Syst Rev 2016 0.75
54 Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study. J Nucl Cardiol 2012 0.75
55 Right superior vena cava drainage into the left atrium revealed by multiples strokes after pacemaker implantation. Heart Rhythm 2012 0.75
56 [Recurrent septicaemia following incomplete removal of pacemaker leads]. Presse Med 2005 0.75
57 Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Arch Cardiovasc Dis 2011 0.75
58 Pneumomediastinum after implantable cardiac defibrillator implantation. Eur Heart J 2010 0.75
59 [Intracardiac conduction disturbances]. Rev Prat 2012 0.75